Home > Oncology > Biosimilars offer effective and cost-effective alternatives to biologics for cancer treatment

Biosimilars offer effective and cost-effective alternatives to biologics for cancer treatment


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Journal
JAMA Oncology
Reuters Health - 16/02/2022 - Biosimilar cancer drugs appear to be as safe and effective as the biologics they replace, and they cost much less, a systematic review and meta-analysis reports. "We found that for three widely-used cancer biologic drugs - bevacizumab, trastuzumab, and rituximab - biosimilar drugs worked just as well as biologics in terms of their effectiveness," senior study author Dr. Aaron Kesselheim of Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, told Reuters Health by email. Even though fewer than 2% of patients in the United States use biologic drugs, the authors write in The Lancet Oncology, biologics earned manufacturers $211 billion in revenue in 2019 and represented 43% of national drug sales. Dr. Kesselheim and his colleagues searched standard medical databases for articles and abstracts in English published until April 2021. They included all publications that compared a disease-modifying cancer bi...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on